M.D. Reza

Director, R&d Process Development at Nature's Way

Md Reza has a diverse work experience in the field of research and development (R&D) within the pharmaceutical and health science industries. Starting in 2007, they worked as a Research and Development Scientist at Popular Pharmaceuticals Limited, focusing on early product development for various solid dosage forms. Md then joined Madina Industrial Corp as a Senior Scientist in R&D from 2009 to 2011.

In 2011, Md Reza became a Principal Scientist in R&D at Avet Pharmaceuticals Inc., where they led the development of two FDA Rx Generic products in Soft Gelatin capsule dosage forms. Md then transitioned to Pharmavite in 2013, taking on the role of Manager for NPD Commercialization & Technical Operations. During this time, they managed two functional departments and oversaw the technical operations for the Opelika site, as well as NPD commercialization for gummy and softgel products in Pharmavite's East coast sites.

From 2018 to 2021, Md Reza worked as a Product Development Manager in R&D for The Nature's Bounty Co., where they worked with brands such as Nature's Bounty, Solgar, Osteo Bi Flex, Puritans Pride, Sundown, and Ester-C. In 2021, they moved to Nestlé Health Science as a Product Development Senior Manager in R&D, responsible for managing the R&D Center of Excellence for Enjoyment Dosage Forms of NHSc Wellness Brands.

Md is currently the Director of R&D Process Development at Nature's Way, a position they have held since 2023.

Md Reza has a Master of Science (MS) degree in Pharmaceutical Sciences/Industrial Pharmacy from Long Island University. Additionally, Reza holds a Doctor of Philosophy (PhD) degree in Pharmaceutical Sciences from Auburn University. There is no available information regarding the start and end years for both of these degrees. It is also mentioned that Reza has studied Enhanced Gummies & Jellies at the University of Wisconsin-Madison, but no specific degree is provided.

Links

Timeline

  • Director, R&d Process Development

    January, 2023 - present

View in org chart